Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313406601> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4313406601 endingPage "491" @default.
- W4313406601 startingPage "485" @default.
- W4313406601 abstract "Background/Aim: The clinical hazard of prostate cancer development after five-alpha reductase inhibitors (5ARI) treatment among benign prostate hyperplasia (BPH) patients is still controversial. The aim of this study was to evaluate the epidemiological features of BPH patients treated in a single institute to identify risk factors associated with prostate cancer development. Patients and Methods: We retrospectively analyzed patients who were diagnosed with BPH and received alpha blockers (AB) only or 5ARI between January 2007 and December 2012 and followed up until death or December 2020. The primary study outcome was prostate cancer and high-grade prostate cancer. Results: Of the 5,122 included patients, 14.9% (762/5,122) received 5ARI during their BPH treatment. The median age, initial prostate specific antigen (PSA) levels and the PSA change were significantly higher in the 5ARI group compared to those of the AB group. The prostate cancer diagnosis rate was higher in the 5ARI group, and the percentage of high-grade prostate cancer was not different between the two groups. In total, 1,715 (33.5%) patients were recorded dead, and the median follow-up period was longer in the 5ARI group. In Cox regression analysis, only age and initial PSA levels were significantly associated with prostate cancer. Late PSA was the only independent factor associated with high-grade prostate cancer development. Conclusion: Our real-world data revealed that age, initial PSA, and late PSA levels were associated with prostate cancer and high-grade prostate cancer diagnosis among BPH patients. Furthermore, 5ARI use had no effect on prostate cancer patient survival. However, PSA assessment during follow-up is still required in our institutional practice to avoid delayed diagnosis." @default.
- W4313406601 created "2023-01-06" @default.
- W4313406601 creator A5004447689 @default.
- W4313406601 creator A5013532910 @default.
- W4313406601 creator A5025654001 @default.
- W4313406601 creator A5030527407 @default.
- W4313406601 creator A5037179166 @default.
- W4313406601 creator A5041006089 @default.
- W4313406601 creator A5042850501 @default.
- W4313406601 creator A5046142107 @default.
- W4313406601 creator A5078685484 @default.
- W4313406601 creator A5091683814 @default.
- W4313406601 date "2022-12-30" @default.
- W4313406601 modified "2023-10-09" @default.
- W4313406601 title "Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia" @default.
- W4313406601 doi "https://doi.org/10.21873/anticanres.16185" @default.
- W4313406601 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36585197" @default.
- W4313406601 hasPublicationYear "2022" @default.
- W4313406601 type Work @default.
- W4313406601 citedByCount "0" @default.
- W4313406601 crossrefType "journal-article" @default.
- W4313406601 hasAuthorship W4313406601A5004447689 @default.
- W4313406601 hasAuthorship W4313406601A5013532910 @default.
- W4313406601 hasAuthorship W4313406601A5025654001 @default.
- W4313406601 hasAuthorship W4313406601A5030527407 @default.
- W4313406601 hasAuthorship W4313406601A5037179166 @default.
- W4313406601 hasAuthorship W4313406601A5041006089 @default.
- W4313406601 hasAuthorship W4313406601A5042850501 @default.
- W4313406601 hasAuthorship W4313406601A5046142107 @default.
- W4313406601 hasAuthorship W4313406601A5078685484 @default.
- W4313406601 hasAuthorship W4313406601A5091683814 @default.
- W4313406601 hasConcept C121608353 @default.
- W4313406601 hasConcept C126322002 @default.
- W4313406601 hasConcept C126894567 @default.
- W4313406601 hasConcept C143998085 @default.
- W4313406601 hasConcept C207103383 @default.
- W4313406601 hasConcept C2775874879 @default.
- W4313406601 hasConcept C2776235491 @default.
- W4313406601 hasConcept C2777562237 @default.
- W4313406601 hasConcept C2778878792 @default.
- W4313406601 hasConcept C2780192828 @default.
- W4313406601 hasConcept C2781406297 @default.
- W4313406601 hasConcept C2910366748 @default.
- W4313406601 hasConcept C29456083 @default.
- W4313406601 hasConcept C44249647 @default.
- W4313406601 hasConcept C50382708 @default.
- W4313406601 hasConcept C71924100 @default.
- W4313406601 hasConceptScore W4313406601C121608353 @default.
- W4313406601 hasConceptScore W4313406601C126322002 @default.
- W4313406601 hasConceptScore W4313406601C126894567 @default.
- W4313406601 hasConceptScore W4313406601C143998085 @default.
- W4313406601 hasConceptScore W4313406601C207103383 @default.
- W4313406601 hasConceptScore W4313406601C2775874879 @default.
- W4313406601 hasConceptScore W4313406601C2776235491 @default.
- W4313406601 hasConceptScore W4313406601C2777562237 @default.
- W4313406601 hasConceptScore W4313406601C2778878792 @default.
- W4313406601 hasConceptScore W4313406601C2780192828 @default.
- W4313406601 hasConceptScore W4313406601C2781406297 @default.
- W4313406601 hasConceptScore W4313406601C2910366748 @default.
- W4313406601 hasConceptScore W4313406601C29456083 @default.
- W4313406601 hasConceptScore W4313406601C44249647 @default.
- W4313406601 hasConceptScore W4313406601C50382708 @default.
- W4313406601 hasConceptScore W4313406601C71924100 @default.
- W4313406601 hasIssue "1" @default.
- W4313406601 hasLocation W43134066011 @default.
- W4313406601 hasLocation W43134066012 @default.
- W4313406601 hasOpenAccess W4313406601 @default.
- W4313406601 hasPrimaryLocation W43134066011 @default.
- W4313406601 hasRelatedWork W1979522210 @default.
- W4313406601 hasRelatedWork W2020094909 @default.
- W4313406601 hasRelatedWork W2038565121 @default.
- W4313406601 hasRelatedWork W2041830186 @default.
- W4313406601 hasRelatedWork W2043487886 @default.
- W4313406601 hasRelatedWork W2074491453 @default.
- W4313406601 hasRelatedWork W2131125612 @default.
- W4313406601 hasRelatedWork W2223219573 @default.
- W4313406601 hasRelatedWork W2768915954 @default.
- W4313406601 hasRelatedWork W4313232132 @default.
- W4313406601 hasVolume "43" @default.
- W4313406601 isParatext "false" @default.
- W4313406601 isRetracted "false" @default.
- W4313406601 workType "article" @default.